Tue, December 6, 2011
Mon, December 5, 2011
Sun, December 4, 2011
Sat, December 3, 2011
Fri, December 2, 2011
Thu, December 1, 2011
[ Thu, Dec 01st 2011 ] - Market Wire
Mortgage Rates Inch Higher
Wed, November 30, 2011
Tue, November 29, 2011

Cepheid to Webcast Upcoming Financial Presentations


//science-technology.news-articles.net/content/2 .. to-webcast-upcoming-financial-presentations.html
Published in Science and Technology on by Market Wire   Print publication without navigation


Cepheid to Webcast Upcoming Financial Presentations -- SUNNYVALE, Calif., Dec. 1, 2011 /PRNewswire/ --

Cepheid to Webcast Upcoming Financial Presentations

[ ]

SUNNYVALE, Calif., Dec. 1, 2011 /PRNewswire/ -- Cepheid (NASDAQ: [ CPHD ]) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.

Oppenheimer Healthcare Conference, New York, NY
Tuesday, December 13, 2011 at 10.50 a.m. Eastern Time

J.P. Morgan Healthcare Conference, San Francisco, CA
Thursday, January 12, 2012 at 10.30 a.m. Pacific Time

To access the live webcasts for these events, please visit Cepheid's website at [ www.cepheid.com/investors ] at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: [ CPHD ]) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit [ www.cepheid.com ].



CONTACTS:




For Media Inquiries:

For Investor Inquiries:



Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400-8377

[ communications@cepheid.com ]

Jacquie Ross

Cepheid Investor Relations

Tel: (408) 400-8329

[ investor.relations@cepheid.com ]






SOURCE Cepheid

[ Back to top ]

RELATED LINKS
[ http://www.cepheid.com ]


Publication Contributing Sources